Evidence map›Paper›PMID 38720345›Full record

ArticleJournal of translational medicine2024

Fluorinated hydroxyapatite conditions a favorable osteo-immune microenvironment via triggering metabolic shift from glycolysis to oxidative phosphorylation.

Kaidi Chen, Seongmin Ha, Leyao Xu, Chengwu Liu, Yuanxiang Liu, Xiayi Wu, Zhipeng Li, Shiyu Wu, Bo Yang, Zhuofan Chen

Erratum issuedAbstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kaidi Chen *Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Seongmin Ha *Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Leyao XuHospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Chengwu LiuHospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Yuanxiang LiuHospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Xiayi WuHospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Zhipeng LiHospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Shiyu WuHospital of Stomatology, Sun Yat-sen University, Guangzhou, China. wushy55@mail.sysu.edu.
Bo YangHospital of Stomatology, Sun Yat-sen University, Guangzhou, China. yangb86@mail.sysu.edu.cn.
Zhuofan ChenHospital of Stomatology, Sun Yat-sen University, Guangzhou, China. chzhuof@mail.sysu.edu.cn.ORCID 0000-0002-3341-1485

Funding

China Postdoctoral Science Foundation 2020M683131Guangdong Basic and Applied Basic Research Foundation 2023A1515010205National Natural Science Foundation of China 81970975National Natural Science Foundation of China 82001095National Natural Science Foundation of China 82001109Science and Technology Program of Guangzhou SL2022A04J01709the State Key Laboratory of Oral Diseases (SKLOD) Open Fund SKLOD2022OF06
6 · The paper itself

Abstract

backgroundBiological-derived hydroxyapatite is widely used as a bone substitute for addressing bone defects, but its limited osteoconductive properties necessitate further improvement. The osteo-immunomodulatory properties hold crucial promise in maintaining bone homeostasis, and precise modulation of macrophage polarization is essential in this process. Metabolism serves as a guiding force for immunity, and fluoride modification represents a promising strategy for modulating the osteoimmunological environment by regulating immunometabolism. In this context, we synthesized fluorinated porcine hydroxyapatite (FPHA), and has demonstrated its enhanced biological properties and osteogenic capacity. However, it remains unknown whether and how FPHA affects the immune microenvironment of the bone defects.

methodsFPHA was synthesized and its composition and structural properties were confirmed. Macrophages were cultured with FPHA extract to investigate the effects of FPHA on their polarization and the related osteo-immune microenvironment. Furthermore, total RNA of these macrophages was extracted, and RNA-seq analysis was performed to explore the underlying mechanisms associated with the observed changes in macrophages. The metabolic states were evaluated with a Seahorse analyzer. Additionally, immunohistochemical staining was performed to evaluate the macrophages response after implantation of the novel bone substitutes in critical size calvarial defects in SD rats.

resultsThe incorporation of fluoride ions in FPHA was validated. FPHA promoted macrophage proliferation and enhanced the expression of M2 markers while suppressing the expression of M1 markers. Additionally, FPHA inhibited the expression of inflammatory factors and upregulated the expression of osteogenic factors, thereby enhancing the osteogenic differentiation capacity of the rBMSCs. RNA-seq analysis suggested that the polarization-regulating function of FPHA may be related to changes in cellular metabolism. Further experiments confirmed that FPHA enhanced mitochondrial function and promoted the metabolic shift of macrophages from glycolysis to oxidative phosphorylation. Moreover, in vivo experiments validated the above results in the calvarial defect model in SD rats.

conclusionIn summary, our study reveals that FPHA induces a metabolic shift in macrophages from glycolysis to oxidative phosphorylation. This shift leads to an increased tendency toward M2 polarization in macrophages, consequently creating a favorable osteo-immune microenvironment. These findings provide valuable insights into the impact of incorporating an appropriate concentration of fluoride on immunometabolism and macrophage mitochondrial function, which have important implications for the development of fluoride-modified immunometabolism-based bone regenerative biomaterials and the clinical application of FPHA or other fluoride-containing materials.

Indexed as

DurapatiteGlycolysisMacrophagesOxidative PhosphorylationRats, Sprague-DawleyAnimalsBone and BonesCell ProliferationCellular MicroenvironmentMaleMiceOsteogenesisRatsRAW 264.7 CellsSkullSwineDurapatiteBone regenerationFluorideMacrophagesMetabolic shiftOsteo-immunomodulation

Identifiers

PMID38720345
PMCPMC11077739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.